Nasdaq Approves Listing of Staking-enabled Injective ETF

Nasdaq has approved the listing of Canary Capital's Injective exchange-traded fund (ETF). This product features a staking function.

The decision to allow the asset to trade was formalized in a document filed with the U.S. Securities and Exchange Commission (SEC).

Official registration of Form 8-A12B is available in SEC archives at the following link: https://www.sec.gov/Archives/edgar/data/2073616/000199937126024343/canary-8a12b_110326.htm